Date Title Description PDF
24 Oct 2024 On corporate transactions ROVI completes the strategic review of its CDMO business Download
31 Jul 2024 On P&L The Company releases the first half 2024 financial results presentation Download
31 Jul 2024 On P&L The Company releases the press release related to the first half 2024 financial results Download
26 Jun 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives Download
24 Jun 2024 On business and financial situation ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth Download

Pages

Date Title Description PDF
21 Feb 2023 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors Download
16 Feb 2023 On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. Download
09 Jan 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2022 Download
15 Dec 2022 On Corporate Governance The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. Download
04 Oct 2022 On business and financial situation The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value.  Download

Pages

Date Title Description PDF
30 Jul 2014 información sobre resultados Download
30 Jul 2014 información sobre resultados (2) Download
01 Jul 2014 Información sobre dividendos Download
12 Jun 2014 Convocatorias y Acuerdos de Juntas y Asambleas Generales Download
29 Apr 2014 Información sobre resultados (2) Download

Pages